Sari Riihijärvi

Male gender is an adverse prognostic factor in B‐cell lymphoma patients treated with immunochemotherapy *

M. Jerkeman, S. Leppä, M. Taskinen, 2011, European journal of haematology.

Host- and Tumour-related Prognostic Factors in Diffuse Large B-cell Lymphoma

Sari Riihijärvi, 2016 .

High serum vascular endothelial growth factor level is an adverse prognostic factor for high‐risk diffuse large B‐cell lymphoma patients treated with dose‐dense chemoimmunotherapy

H. Holte, M. Eriksson, Ø. Fluge, 2012, European journal of haematology.

Prognostic impact of protein kinase C β II expression in R-CHOP-treated diffuse large B-cell lymphoma patients

M. Jerkeman, S. Leppä, H. Nyman, 2010, Modern Pathology.

Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial

J. Delabie, E. Smeland, H. Holte, 2015, Haematologica.

Time series analysis of the incidence of acute upper respiratory tract infections, COVID-19 and the use of antibiotics in Finland during the COVID-19 epidemic: a cohort study of 833 444 patients

S. Taimela, Oskar Niemenoja, P. Huovinen, 2022, BMJ Open.